Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on October 30, 2026

11 hours ago

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

11 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire

11 hours ago

Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization

Indeterminate GlobeNewswire

11 hours ago

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Indeterminate GlobeNewswire

12 hours ago

Regeneron Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

12 hours ago

Glass-Ceramics Market to Reach $2.7 Billion by 2031 as Semiconductor, Aerospace and Medical Applications Expand

Indeterminate GlobeNewswire

12 hours ago

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

Indeterminate GlobeNewswire

12 hours ago

Repligen Announces $1 Billion Private Convertible Senior Notes Transaction

Indeterminate GlobeNewswire

13 hours ago

Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation

Indeterminate GlobeNewswire

13 hours ago

Tangram gibt bekannt, dass der erste Teilnehmer im Rahmen der Phase-I-Studie mit TGM-148, einem neuartigen RNAi-Prüfpräparat zur Behandlung von Blutungsstörungen, die erste Dosis erhalten hat

Indeterminate GlobeNewswire

13 hours ago

Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques

Indeterminate GlobeNewswire

14 hours ago

Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

Indeterminate GlobeNewswire

15 hours ago

Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health

Indeterminate GlobeNewswire

15 hours ago

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026

Indeterminate GlobeNewswire

16 hours ago

Nicox Reports First Half 2026 Financial Results

Indeterminate GlobeNewswire

16 hours ago

Nicox publie les résultats financiers du premier semestre 2026

Indeterminate GlobeNewswire

16 hours ago

Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded

Indeterminate GlobeNewswire

16 hours ago

Communiqué de presse : T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026

Indeterminate GlobeNewswire

16 hours ago

Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein

Indeterminate GlobeNewswire